Stellar

• Don't Sweat Trump-Xi Meeting, Focus on Q3 Earnings: Deutsche Bank
  Business Insider · Sep 23, 2026
• A carbon material has over 100 times structural steel’s pulling strength. Stellar V signed a nonbinding deal letter.
  Stock Titan · Sep 24, 2026
• XLM Price Prediction: Could Stellar Hit $0.25?
  24/7 Wall St. · Sep 15, 2026
• After stellar H1 results, is Kingfisher 1 of the best UK stocks to buy right now? I’m not so sure…
  Yahoo Finance UK · Sep 23, 2026
• Stellar V Capital (NASDAQ:SVCC) Shares Climb 0.4% - Here's What Happened
  MarketBeat · Sep 25, 2026
• Nvidia's board increases chipmaker's share buyback plan by $150 billion
  WRAL · Sep 28, 2026
• Collect 10% A Year On CIEN Stock Now, Own It 50% Cheaper If It Dips
  Trefis · Sep 22, 2026
• Micron's Earnings: Don't Be Misled By The Guidance, Don't Worry, Q4 Should Be Stellar (MU)
  Seeking Alpha · Sep 28, 2026
• XRP Is Down 14% in 2026 While Stellar Is Up 8%. Which Is the Better Buy Now?
  AOL.com · Sep 23, 2026
• Nasdaq, S&P 500 Futures Pause After Record AI-Driven Rally: AMD, META, BABA, GME, HOOD, GRAB, VKTX Stocks In Focus
  TradingView · Sep 22, 2026
• A natural consolidator with stellar profitability, Rollins hits air pocket on the stock market
  marketscreener.com · Sep 23, 2026
• Prosperity Bancshares director Ned Holmes sells $75,310 in stock
  Investing.com · Sep 23, 2026
• Stellar Now Hosts $2.75 Billion in Tokenized Real-World Assets: What Does It Mean for XLM Holders?
  24/7 Wall St. · Sep 25, 2026
• 5N Plus Stock: The Sleeper Materials Company That Gained 1,357%
  Yahoo! Finance Canada · Sep 19, 2026
• KLIC Up 93.6% in a Year: Should Investors Bet on the Stock Now?
  TradingView · Sep 21, 2026
• Stellar Surpasses Its 50-Week Average, While XRP Lags: Which Payments Coin Will Lead Into Q4?
  24/7 Wall St. · Sep 26, 2026
• This Canadian Semiconductor Stock Is Up 64% Year to Date, and Orders Are Booming
  Yahoo! Finance Canada · Sep 24, 2026
• Why is Vera Therapeutics stock reversing its premarket gains?
  TradingView · Sep 15, 2026
• Could Zanzalintinib's FDA Delay Affect Exelixis' Growth Plans?
  TradingView · Sep 24, 2026

Headlines via Google News. Links open the original publisher.